Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trinity Biotech PLC (NASDAQ:TRIB)

5.53
Delayed Data
As of Mar 27
 +0.06 / +1.10%
Today’s Change
5.20
Today|||52-Week Range
13.68
-20.09%
Year-to-Date
No recent news for Trinity Biotech PLC.

Today’s Trading

Previous close5.47
Today’s open5.39
Day’s range5.39 - 5.65
Volume43,188
Average volume (3 months)110,714
Market cap$132.5M
Dividend yield3.98%
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-76.60%
Earnings growth (this year)-13.69%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-0.33%
P/E ratioNM
Price/Sales1.97
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc+0.08+3.74%
CGIXCancer Genetics Inc+1.15+29.49%
QTNTQuotient Ltd-0.09-1.42%
GALTGalectin Therapeutic...+0.13+5.91%
Data as of 03/27/2017

Financials

Next reporting dateApril 19, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.3M
Annual profit (last year)$5.1M
Net profit margin5.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Ronan O'Caoimh
CFO, Secretary &
Head-Investor Relations
Kevin Tansley
Corporate headquarters
Bray, Wicklow

Forecasts


Search for Jobs